Home Newsfeeds iRadimed Q3 EPS $0.45 Up From $0.23 YoY

iRadimed Q3 EPS $0.45 Up From $0.23 YoY

iRadimed (NASDAQ:IRMD) reported quarterly earnings of $0.45 per share. This is a 95.65 percent increase over earnings of $0.23 per share from the same period last year.

byBenzinga Newsdesk

July 29, 2022

1 minute read

iRadimed (NASDAQ:IRMD) reported quarterly earnings of $0.45 per share. This is a 95.65 percent increase over earnings of $0.23 per share from the same period last year.

What’s Gaining Popularity Among US Teens Battling Obesity? Novo Nordisk’s Weight Loss Drug Wegovy

By Vandana Singh

February 15, 10:05 AM

Rise of adolescent usage of Novo Nordisk's Wegovy for pediatric obesity. Surging demand among families, but concerns linger on the impact of weight-loss drugs on growing children's development.

LLY

Baird Maintains Outperform on Ulta Beauty, Raises Price Target to $500

By Benzinga Newsdesk

August 26, 8:16 AM

Baird analyst Mark Altschwager maintains Ulta Beauty (NASDAQ:ULTA) with a Outperform and raises the price target from $480 to $500.

ULTA

Credit Suisse Maintains Neutral on Netflix, Raises Price Target to $271

By Benzinga Newsdesk

October 19, 6:46 AM

Credit Suisse analyst Douglas Mitchelson maintains Netflix (NASDAQ:NFLX) with a Neutral and raises the price target from $263 to $271.

NFLX

Movers
News

Why Ugg’s Parent-Company Deckers Outdoor Corporation Stock Soared Today

By Erica Kollmann

October 27, 4:43 PM

Deckers Outdoor Corporation (NYSE: DECK) shares traded higher Friday after the company reported a year-over-year increase in second-quarter earnings per share and better-than-expected sales resu

DECK

iRadimed Q3 EPS $0.45 Up From $0.23 YoY

Related Posts

What’s Gaining Popularity Among US Teens Battling Obesity? Novo Nordisk’s Weight Loss Drug Wegovy

Baird Maintains Outperform on Ulta Beauty, Raises Price Target to $500

Credit Suisse Maintains Neutral on Netflix, Raises Price Target to $271

Why Ugg’s Parent-Company Deckers Outdoor Corporation Stock Soared Today